EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹3,566 Cr | ₹3,449 Cr | ₹2,737 Cr | ₹2,523 Cr | ₹2,942 Cr |
What is the latest Total Non-Current Assets ratio of EMCURE PHARMACEUTICALS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹3,566 Cr |
| Mar2024 | ₹3,449 Cr |
| Mar2023 | ₹2,737 Cr |
| Mar2022 | ₹2,523 Cr |
| Mar2021 | ₹2,942 Cr |
How is Total Non-Current Assets of EMCURE PHARMACEUTICALS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,566 Cr | 3.37 | |
| Mar2024 | ₹3,449 Cr | 26.01 | |
| Mar2023 | ₹2,737 Cr | 8.49 | |
| Mar2022 | ₹2,523 Cr | -14.22 | |
| Mar2021 | ₹2,942 Cr | - | |
Compare Total Non-Current Assets of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹34,204.8 Cr | -0.4% | 3.9% | 42.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -0.4% |
3.9% |
42.7% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses